News

You are here

Oct 24, 2014

Last week, the crowdfunding campaign reached the objective of 100,000 € with the contribution of 41 investors. The funding is devoted to the schizophrenia project, where a cognitive enhancer has been discovered. Preclinical experiments will be finished with the money raised. Afterwards, the drug will enter into clinical phase I. We want to thank them all investors for their support in the Iproteos project!

Campaign web page

Oct 24, 2014

On Tuesday 11th of November of 2014, Iproteos will celebrate an Extraordinary shareholders meeting. More information is given in the link below. El martes 11 de Noviembre de 2014, Iproteos celebrará una Reunión extraordinaria de accionistas. Se puede encontrar toda la información necesaria en el siguiente enlace: Iproteos_Convocatoria Junta_Octubre 2014  

Oct 21, 2014

Last Wednesday, 15th of October, the crowdfunding campaign of Iproteos reached the objective of 100,000€.  

Oct 14, 2014

The crowdfunding campaign is about to reach the objective of 100,000€. At the moment, 96,622 € have been raised, with the participation of 39 investors. Once finished the campaign, investors will participate in Iproteos with a 5.14% of the offered shares by Iproteos. This campaign is aimed to the obtaining of funding for the completition of the non-regulatory preclinical studies for the new schizophrenia treatment, IPR19. Iproteos has other two lines of research, one for Parkinson disease, and another one for epilepsia. Do you want to be our investor number 40? Hurry up!

Oct 08, 2014

Teresa Tarragó will participate in the 2nd Red Emprendia Spin, that will take place in Mexico DF the days 29th and 30th of October. RedEmprendia Spin is a meeting that promotes the entrepreneur talent and the strengthening the contribution of the University to the economic development in Latin America. The meeting puts together entrepreneurs, companies, investors, researchers and students in a unique opportunity to share experiences and acquire knowledge on R+D done at universities, new technologies, the latest trends or entrepreneurship.